Theme news

Austin, Texas – September 29, 2026 -- CyberRatings.org has published new Cloud Network Firewall (CNFW) test results showing security effectiveness among nine evaluated products ranging from 0% to 99.95%, with only four earning a Recommended rating.

Four vendors clear the bar with 99.7% or higher security effectiveness

Fortinet FortiGate Next-Generation Firewall, HPE Juniper Networking vSRX Next Generation Firewall, Palo Alto Networks VM-Series Next-Generation Firewall, and Versa Networks Next Generation Firewall each achieved 99.7% or higher in Security Effectiveness, earning Recommended ratings. Tests were conducted by NSS Labs, CyberRatings' official testing partner, using the Cloud Network Firewall Test Methodology v4.1.

Stamford, Conn. – – September 29, 2026 -- Tronox Holdings plc (NYSE: TROX) and JX Advanced Metals Corporation (TYO: 5016) have signed a cooperation and investment agreement to jointly fund approximately $32 million on a 50/50 basis for feasibility studies covering new rare earth processing facilities in Australia and the United States.

Companies commit $32 million to feasibility work across two continents

The funding will support a definitive feasibility study for a proposed rare earth cracking and leaching facility in Western Australia and a pre-feasibility study for a rare earth oxide refinery in the United States, alongside development of a US-based pilot plant capable of producing initial quantities of high-purity rare earth oxides.

New York – – September 29, 2026 -- Deloitte analysis projects that shifting U.S. healthcare from reactive treatment to proactive, life-stage-aware care could generate $527 billion in additional potential spending on women's health by 2030 compared with a baseline trajectory.

Deloitte models a 20-year health span gain from earlier intervention

Under a prevention and improved disease-management scenario, Deloitte's actuarial Future of Health model — built on five years of medical and pharmacy claims data from nearly 60 million lives — estimates women's health span could increase by up to 20 years in the long run. The firm's report, "How a $527 billion growth opportunity in women's health can improve health outcomes," compares a baseline 2030 spending trajectory against a scenario emphasizing earlier detection and management across 22 disease states.

Washington, D.C. – September 29, 2026 -- LUNGevity Foundation has committed $2 million to fund two three-year clinical research projects aimed at improving the diagnosis of indeterminate pulmonary nodules (IPNs), a condition affecting more than 1.5 million Americans annually after routine chest CT scans.

The funding, awarded through the 2026 RTFCCR/LUNGevity Early Detection Award in partnership with the Rising Tide Foundation for Clinical Cancer Research (RTFCCR), targets a diagnostic gap that currently forces many patients into unnecessary invasive procedures or prolonged uncertainty when non-invasive tools fail to determine whether a lung nodule is benign or malignant.

Shanghai – September 29, 2026 -- Envision Energy has secured a spot on Fortune's 2026 Change the World list for the third time, recognized for its Mission Gobi initiative pairing AI computing infrastructure with renewable energy in desert regions.

Fortune honors Envision among 50 global companies tackling social and environmental challenges

The 2026 list includes Alphabet, Anthropic and CATL among other honorees. Envision's selection centers on Mission Gobi's approach to converging AI and green energy, positioning abundant renewable resources as infrastructure for next-generation computing.

Mission Gobi targets 5GW of green AI computing capacity by 2030

Launched in June 2026, the initiative aims to build green AI computing capacity across desert and arid regions worldwide, drawing on wind and solar resources in areas historically viewed as energy-constrained.

Berlin – September 29, 2026 -- Huawei has launched Intelligent RAIL 2.0, a portfolio of 20 scenario-based solutions targeting railway construction, passenger and freight transport, and facility maintenance, unveiled at InnoTrans 2026 held September 22-25 in Berlin.

Huawei has already deployed rail technology across 180,000 kilometers of track worldwide

The company says it now serves more than 50 major railway customers and over 300 urban rail lines globally, positioning the new platform as an expansion of an existing large-scale deployment base rather than a market entry.

San Francisco – September 29, 2026 -- Innovent Biologics reported an 84.6% overall response rate for its trispecific antibody IBI3003 at the recommended Phase 2 dose in heavily pretreated multiple myeloma patients, data presented in an oral session at the 23rd International Myeloma Society Annual Meeting 2026.

Trial identifies 360 μg/kg as the optimal dose after testing three dose levels

Among 26 patients treated at 360 μg/kg with a median follow-up of 7.57 months, median progression-free survival has not yet been reached. The cohort produced 11 stringent complete responses, 4 very good partial responses, and 7 partial responses. Response rates climbed to 94.7% among 19 patients who had received only 2 to 4 prior lines of therapy, and 92.3% among 13 patients without extramedullary disease.

London – September 29, 2026 -- Reactive Technologies has launched Nyquist, a technology licensing programme giving utilities, technology providers and equipment manufacturers access to its patented Edge-to-Cloud AI foundation for grid measurement and analytics.

Nyquist opens core sensing and AI technologies to external partners

The programme lets partners integrate Reactive Technologies' proprietary capabilities directly into their own products, covering high-fidelity measurement and waveform capture, precise time-synchronisation, digital signal processing, edge AI, connectivity, data infrastructure and grid analytics. Partners avoid building these complex sensing and processing systems from scratch, cutting development time for grid-monitoring products.

London – September 29, 2026 -- Pearson (FTSE: PSON.L) has agreed to acquire Workera, an AI-native skills intelligence platform used by enterprises including ServiceNow, Accenture and the United States Space Force to verify workforce capability.

Pearson targets enterprise skills verification gap as AI reshapes workforce needs

Workera combines agentic AI, psychometrics and adaptive assessment to measure employee proficiency through role-specific scenarios and simulations, rather than relying on self-reported skills data. The platform gives business leaders a live baseline of workforce capability, including AI fluency, and routes employees to targeted development that closes specific skill gaps. It also verifies whether skills improved post-training, offering measurable ROI on learning investments, and informs hiring, internal mobility and workforce planning decisions.

Taipei – – September 29, 2026 -- ORing Industrial Networking, a Taiwan-based industrial networking specialist with 20 years of market experience, showcased its next-generation IRoN railway Ethernet switch portfolio at InnoTrans 2026.

ORing unveils IRoN switches for onboard rail networks at InnoTrans 2026

ORing's networking equipment has already been deployed in passenger and freight rail projects across Europe, the United States, and Asia. The company positions the IRoN Series as a response to trains carrying more connected devices and data-intensive services, where critical control communications now share infrastructure with video surveillance and passenger information systems.

Kyoto – September 29, 2026 -- Nuvoton Technology Corporation Japan (NTCJ) will begin sampling its KA85010UA battery monitoring IC in January 2027, a 26-cell chip that integrates electrochemical impedance spectroscopy (EIS) directly on-chip while cutting PCB temperature rise during measurements by approximately 93% compared with conventional methods.

Inductor-based design slashes power loss and heat by 93%

The KA85010UA replaces the industry-standard resistor method with NTCJ's proprietary inductor approach for EIS measurement, reducing both energy loss and PCB temperature rise by roughly 93%, according to company evaluations. The lower thermal footprint allows EIS functionality to be embedded directly into automotive batteries and energy storage systems without dedicated external measurement equipment.

Espoo – September 29, 2026 -- Valmet Oyj's Board of Directors has confirmed that the second instalment of its 2025 dividend, EUR 0.67 per share, will be paid on October 7, 2026.

Shareholders on record October 1 qualify for payout

The dividend will go to shareholders registered in Valmet's shareholders' register held by Euroclear Finland Oy on the record date of October 1, 2026.

Total 2025 dividend reaches EUR 1.35 per share in two tranches

Valmet's Annual General Meeting in 2026 approved a total dividend of EUR 1.35 per share for the 2025 financial year, split into two instalments. The first tranche of EUR 0.68 per share was paid on April 9, 2026.

Payout ratio hits 89%, well above policy floor

Valmet's dividend policy commits to distributing at least 50% of the period's profit as dividend. The 2025 payout ratio stands at 89%, substantially exceeding that minimum threshold.

Shenzhen, China – September 29, 2026 -- i2Cool has expanded its passive radiative cooling fabric line with two electricity-free products, i2Umbrella Fabric-Hyber and i2Tarpaulin, that lower surface temperatures without power or refrigerants.

New umbrella fabric cuts ambient temperature by 5.2°C without electricity

i2Umbrella Fabric-Hyber, engineered for umbrellas, patio shades and outdoor canopies, achieves solar reflectivity of up to 76% and mid-infrared emissivity of up to 96%. In controlled outdoor testing, the fabric produced internal temperatures 5.2°C cooler than unshaded areas and 2.4°C cooler than conventional silver-coated sun-protection fabrics. The material also blocks 99% of UV radiation and offers full blackout capability with high water repellency.

Washington D.C. – September 29, 2026 -- Implantica AG launched its FDA-approved RefluxStop device in the U.S. market at the American Foregut Society (AFS) 2026 Annual Meeting, drawing an over-capacity crowd of more than 120 surgeons and gastroenterologists that forced organizers to turn away additional attendees.

FDA approval opens U.S. market for non-encircling GERD device

Following its recent Premarket Approval (PMA) from the U.S. Food and Drug Administration, RefluxStop entered a U.S. GERD treatment market estimated at 78 million patients. Unlike conventional anti-reflux surgeries that wrap around the esophagus, RefluxStop is designed to restore natural anatomy without encircling the food passageway, aiming to reduce side effects such as dysphagia and inability to belch or vomit.

Linköping – – September 29, 2026 -- Swedish medical imaging IT firm Sectra (STO: SECT B) has signed a partner agreement with S&S Partners to enter Brazil, Latin America's largest healthcare market, with an initial focus on its cloud-based enterprise imaging platform Sectra One Cloud.

Brazil's 7,100 hospitals drive shift from on-premise to cloud imaging

Brazil operates approximately 7,100 hospitals, with the private sector accounting for the majority of advanced imaging investment. Major private hospital groups are pushing the market away from on-premise capital purchases toward subscription-based cloud platforms, a shift Sectra says is already gaining momentum.

Torbjörn Kronander, President and CEO at Sectra, said the partnership with S&S Partners provides access to the relationships and local market knowledge required for entry into Brazil.

Indianapolis – September 29, 2026 -- Eli Lilly and Company (NYSE: LLY) reported that its oral GLP-1 drug Foundayo (orforglipron) at 17.2 mg produced 1.5% greater weight loss and 0.3% greater A1C reduction than oral semaglutide 25 mg over 52 weeks in adults with type 2 diabetes, based on an indirect treatment comparison presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan.

Indirect analysis draws on ACHIEVE-3 and PIONEER PLUS trial data

The comparison, covariate-adjusted for gender, age, baseline A1C and baseline weight, found weight-loss differences ranging from 1.5% to 2.4% and A1C reductions of 0.3% to 0.6% in favor of Foundayo 17.2 mg across multiple statistical methods. The 95% confidence interval for weight loss was -2.7% to -0.2%, and for A1C reduction was -0.6% to -0.1%.

Valencia – – September 29, 2026 -- Arthex Biotech has appointed Glenn Sblendorio, former CEO of IVERIC bio, as Chairman of its Board of Directors as the clinical-stage RNA therapeutics company advances its lead program ATX-01 through Phase I/IIa trials for myotonic dystrophy type 1 (DM1).

Sblendorio brings three decades of biotech exit experience to Arthex's board

Sblendorio most recently led IVERIC bio, Inc. as CEO until its acquisition by Astellas Pharma, Inc. He previously served as President and Chief Financial Officer of The Medicines Company through its acquisition by Novartis, and as Executive Vice President and CFO of Eyetech Pharmaceuticals, Inc. until it was acquired by OSI Pharmaceuticals, Inc. Earlier in his career he was a Managing Director at MPM Capital Advisors.

Oslo, Norway – September 29, 2026 -- Nel ASA has secured a purchase order worth approximately USD 12 million from Collins Aerospace for PEM electrolyser stacks destined for US Navy submarine life-support systems. The order was placed through Nel Hydrogen US, a subsidiary of the Oslo-listed hydrogen technology company (OSE: NEL).

Collins Aerospace extends long-running defence procurement with Nel

The stacks will generate oxygen for submarine crews, an application where equipment failure carries direct safety consequences. Nel's Chief Commercial Officer, Todd Cartwright, said the order extends a long-standing cooperation with Collins Aerospace built around reliable oxygen generation for demanding submarine applications, and confirms the continued relevance of the company's PEM technology and manufacturing capabilities.

Fremont, Calif. – September 29, 2026 -- Leopard Imaging will unveil eight new camera and AI perception platforms at VISION 2026, the machine vision trade show running October 6-8 in Stuttgart, Germany, at Hall 10, Booth 10G79.

Sirius Max combines Lumotive beam-steering with iToF depth sensing for long-range robotics perception

The compact RGB + depth platform supports programmable beam-steered illumination and embedded synchronization for software-defined 3D scanning in autonomous systems.

ASTRO Stereo Camera runs on NVIDIA Jetson Thor with dual 5.1MP global-shutter sensors

The system integrates IR projection, illumination, and NVIDIA Holoscan 10GigE connectivity to deliver synchronized RGB + IR stereo imaging, depth mapping, and 3D reconstruction for AI perception pipelines.

Amsterdam – September 29, 2026 -- Nearly $300 million in European spend has now moved through Arkestro's predictive procurement platform, with regional volume growing 93% year over year, the company announced at DPW Amsterdam 2026.

Baseline spend in international procurement events surged 330% from 2024 to 2025

Arkestro projects a further 47% increase in 2026 as existing global customers extend the platform into additional European teams, categories and supplier networks. The company said the growth reflects enterprises seeking faster procurement decisions amid market volatility.

Platform users across Europe grew 78% year over year

Arkestro's buyer and supplier interactions now span 34 countries, and customers running completed European procurement events have generated approximately 10% average savings, the company said.